Tech Company M&A Transactions
TetraGenetics Acquisition
TetraGenetics was bought by AbCellera. The transaction was announced on 9/14/2002 2:00:00 PM. No transaction price was released.
Transaction Overview
Company Name
Acquired By
Announced On
9/14/2002 2:00:00 PM
Transaction Type
M&A
Amount
Unknown
M&A Terms
The all-cash transaction includes an undisclosed upfront payment, the potential for payments based on the achievement of technical milestones, and additional development and commercial milestone payments related to successfully developed therapeutics.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
91 Mystic St.
Arlington, MA 02474
USA
Arlington, MA 02474
USA
Phone
Website
Email Address
Overview
TetraGenetics is an entrepreneurial biotech company focused on the discovery of novel therapeutics for autoimmune disease and pain. We are the world leader in recombinant human ion channel protein production using our proprietary TetraExpress® system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Kahn
Chief Financial Officer
Kevin O'Brien
Chief Scientific Officer
Theodore Clark
VP - R & D
Paul Colussi
Browse more venture capital transactions:
Prev: 8/20/2002: Dune Networks venture capital transaction
Next: 11/20/2002: Etenna venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs